SCHEL, LEONARDUS C. – Trademark Portfolio

Entity Type: 01

SCHEL, LEONARDUS C. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OPTIMUN. The owner is based in EVANS, GA.

4076 STARVIEW LANE

EVANS, GA 30809

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OPTIMUN
OPTIMUN
Registered 2000

Trademark Classifications

SCHEL, LEONARDUS C.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SCHEL, LEONARDUS C. have?

SCHEL, LEONARDUS C. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SCHEL, LEONARDUS C. file in?

SCHEL, LEONARDUS C. files trademarks across 2 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.

What are SCHEL, LEONARDUS C.'s most well-known trademarks?

SCHEL, LEONARDUS C.'s registered trademark portfolio includes well-known marks such as OPTIMUN. These are among 1 currently registered trademark in the portfolio.

What is SCHEL, LEONARDUS C.'s trademark registration success rate?

SCHEL, LEONARDUS C. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.